A HEMODIALYSIS PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE

被引：0
|
作者：
Hiraga, Junji [1 ]
Nishimura, Hayato [2 ]
Kurata, Hisashi [2 ]
Kagami, Yoshitoyo [1 ]
机构：
[1] Toyota Kosei Hosp, Dept Hematol, Toyota, Japan
[2] Toyota Kosei Hosp, Dept Nephrol, Toyota, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-21-3
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Disseminated Varicella-Zoster Virus Infection Following Azacitidine in a Patient With Myelodysplastic Syndrome
    Zhou, Guiyun
    Houldin, Arlene D.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (03) : 280 - 284
  • [42] Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment
    Georg Feldmann
    Peter Brossart
    Marie von Lilienfeld-Toal
    Annals of Hematology, 2013, 92 : 1577 - 1579
  • [43] Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment
    Feldmann, Georg
    Brossart, Peter
    von Lilienfeld-Toal, Marie
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1577 - 1579
  • [44] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [45] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Kataoka, Asami
    Mizumoto, Chisaki
    Kanda, Junya
    Iwasaki, Makoto
    Sakurada, Maki
    Oka, Tomomi
    Fujimoto, Masakazu
    Yamamoto, Yosuke
    Yamashita, Kohei
    Nannya, Yasuhito
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 919 - 924
  • [46] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [47] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Asami Kataoka
    Chisaki Mizumoto
    Junya Kanda
    Makoto Iwasaki
    Maki Sakurada
    Tomomi Oka
    Masakazu Fujimoto
    Yosuke Yamamoto
    Kohei Yamashita
    Yasuhito Nannya
    Seishi Ogawa
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2023, 117 : 919 - 924
  • [48] Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
    Dae-Young Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Kyoo-Hyung Lee
    Yoe-Kyeoung Kim
    Jae Sook Ahn
    Hyeoung-Joon Kim
    Inho Kim
    Sung-Soo Yoon
    Seonyang Park
    Sung Hwa Bae
    Soo-Mee Bang
    Hong Ghi Lee
    Ho-Jin Shin
    Jae Hoon Lee
    Yoo Hong Min
    Jong-Ho Won
    Yeung-Chul Mun
    Doyeun Oh
    Annals of Hematology, 2010, 89 : 15 - 23
  • [49] WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine
    Falconi, Giulia
    Fabiani, Emiliano
    Ottone, Tiziana
    Piciocchi, Alfonso
    Lavorgna, Serena
    Criscuolo, Marianna
    Fianchi, Luana
    Gurnari, Carmelo
    Postorino, Massimiliano
    Picardi, Alessandra
    Palmieri, Raffaele
    Lo-Coco, Francesco
    Voso, Maria Teresa
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 979 - 982
  • [50] Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Kim, Yoe-Kyeoung
    Ahn, Jae Sook
    Kim, Hyeoung-Joon
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Bae, Sung Hwa
    Bang, Soo-Mee
    Lee, Hong Ghi
    Shin, Ho-Jin
    Lee, Jae Hoon
    Min, Yoo Hong
    Won, Jong-Ho
    Mun, Yeung-Chul
    Oh, Doyeun
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 15 - 23
12345